Hsia, J., Szarek, M., Anand, S., Patel, M. R., Debus, S., Berkowitz, S. D., … Bonaca, M. P. (2021). Rivaroxaban in Patients With Recent Peripheral Artery Revascularization and Renal Impairment: The VOYAGER PAD Trial. J Am Coll Cardiol, 78(7), 757–759. https://doi.org/10.1016/j.jacc.2021.06.021

Hsia, Judith, Michael Szarek, Sonia Anand, Manesh R. Patel, Sebastian Debus, Scott D. Berkowitz, Eva Muehlhofer, Lloyd P. Haskell, Rupert M. Bauersachs, and Marc P. Bonaca. “Rivaroxaban in Patients With Recent Peripheral Artery Revascularization and Renal Impairment: The VOYAGER PAD Trial.” J Am Coll Cardiol 78, no. 7 (August 17, 2021): 757–59. https://doi.org/10.1016/j.jacc.2021.06.021.

Hsia J, Szarek M, Anand S, Patel MR, Debus S, Berkowitz SD, et al. Rivaroxaban in Patients With Recent Peripheral Artery Revascularization and Renal Impairment: The VOYAGER PAD Trial. J Am Coll Cardiol. 2021 Aug 17;78(7):757–9.

Hsia, Judith, et al. “Rivaroxaban in Patients With Recent Peripheral Artery Revascularization and Renal Impairment: The VOYAGER PAD Trial.” J Am Coll Cardiol, vol. 78, no. 7, Aug. 2021, pp. 757–59. Pubmed, doi:10.1016/j.jacc.2021.06.021.

Hsia J, Szarek M, Anand S, Patel MR, Debus S, Berkowitz SD, Muehlhofer E, Haskell LP, Bauersachs RM, Bonaca MP. Rivaroxaban in Patients With Recent Peripheral Artery Revascularization and Renal Impairment: The VOYAGER PAD Trial. J Am Coll Cardiol. 2021 Aug 17;78(7):757–759.